Kurapa kweCAR-T kweMultiple Myeloma (MM)

Multiple Myeloma (MM) imhando yegomarara rinokanganisa masero eplasma mumongo wemapfupa. Rinozivikanwa nekuoma kwaro uye kwakasiyana-siyana, kazhinji zvichikonzera kudzokera shure uye kuramba kurapwa kwechinyakare. Kunyangwe chemotherapy, kuisirwa masero ekutanga, uye mishonga mitsva zvakava nemigumisiro iri nani, varwere vazhinji vanozopedzisira vatarisana nekusagona kurapwa. Kurapa kweCAR-T (Chimeric Antigen Receptor T-cell) ikurapa kwakakura kwakaratidza kubudirira kukuru mukurapa myeloma yakawanda inodzokera shure uye isingadzoreki, ichipa mhinduro inovimbisa kune varwere vane sarudzo shoma.

Kurapa neCAR-T kunosanganisira kugadzirisa T-cells dzemurwere kuti azive zviri nani uye arwise masero ekenza. Kune myeloma yakawanda, masero eCAR-T akagadzirwa kuti arwise BCMA (B-cell maturation antigen), puroteni inowanikwa pamusoro pemasero emyeloma. Mushure mekugadziriswa majini, aya maT-cell anodzoserwa mumuviri wemurwere, kwaanotsvaga nekuparadza masero ekenza, izvo zvinogona kukonzera kurerukirwa uye kurarama kwenguva refu.

• Kushanda Kwakanyanya muRelapsed/Refractory MM: Kurapa kweCAR-T kwakaratidza kubudirira kukuru muvarwere vane myeloma yakawanda inodzokera shure kana isingashande, kazhinji vachiwana kuregererwa kwakakwana kana kuti chirwere chidiki chekare (MRD).
• Kunyatsonangwa Kwakanangana: Nekutarisa BCMA, kurapwa kweCAR-T kunorwisa masero emyeloma, kuchichengetedza nyama ine hutano uye kuchideredza migumisiro yakaipa kana tichienzanisa nekurapa kwakajairika.
• Yakagadzirirwa Munhu Uye ItsvaKurapa uku kunoshandisa masero eT emurwere, zvichiita kuti pave nehurongwa hwekurapa hwakasiyana-siyana. Izvi zvinobatsirawo kuderedza njodzi yekurambwa.
• Kuregererwa Kwenguva Refu: Varwere vazhinji vanorapwa neCAR-T therapy vanowana mhinduro dzinogara kwenguva refu, vamwe vachiramba vachipora kwemakore, kunyangwe mushure mekunge mamwe marapirwo akundikana.

• Kuunganidzwa kwemasero eTDanho rekutanga rinosanganisira kuunganidza maT-cell kubva muropa remurwere uchishandisa leukapheresis, maitiro akafanana nekupa ropa.
• Kugadzira maT-cells: Aya maT-cell anozotumirwa kurabhoritari, uko anogadziriswa majini kuti abudise CAR chaiyo kuBCMA, zvichiwedzera kugona kwawo kuziva nekuuraya masero emyeloma.
• Kuiswa kweCAR-T Cells: Mushure mekuwedzerwa murabhoritari, maT-cell akagadzirwa anodzoserwa muropa remurwere kuburikidza neIV.
• Kuongorora uye Kupora: Mushure mekuisirwa mushonga, varwere vanoongororwa kuti vaone kana paine migumisiro yakaipa yakadai se cytokine release syndrome (CRS) kana neurotoxicity. Migumisiro iyi inowanzo gadziriswa nekubatsirwa kwechiremba uye kuongororwa.

• Tekinoroji yeCAR-T Yemazuva AnoBIOOCUS inoshandisa kufambira mberi kwazvino mu tekinoroji yeCAR-T kuti ive nechokwadi chekurapa kwemhando yepamusoro uye mhedzisiro yakanaka kune varwere veMM.
• Nyanzvi Yekurapa Yepamusoro-soro Pasi Rose: Chikwata chedu chenyanzvi mukurapa ropa nezvirwere zvinodzivirira muviri chinopa rubatsiro rwemunhu oga, zvichiita kuti murwere wega wega awane kurapwa kwakanakisisa nekuda kwemamiriro ake akasiyana.
• Rekodhi Yakaratidzwa: Takarapa varwere vakawanda veMM neCAR-T therapy, uye vazhinji vakawana zororo rinoshamisa uye rinogara kwenguva refu.
• Rutsigiro Rwakakwana rweVarwere Vepasi Pose: BIOOCUS inopa rutsigiro rwakazara kuvarwere vekune dzimwe nyika, ichikutungamira mumatanho ese ekurapwa, kubva pakubvunzurudzwa kwekutanga kusvika pakutarisirwa mushure mekurapwa.

• Uchapupu hweKliniki uye Mwero weKubudirira

  Kurapa kweCAR-T kwemultiple myeloma kwaratidza mhedzisiro inoshamisa mukuyedzwa kwekiriniki uye munzvimbo chaidzo. Kunyanya, kwaratidza kushanda zvakanaka muvarwere vakadzokera shure mushure mekurapwa kakawanda, vamwe vachiwana zororo rakazara kana MRD-negative status.

  • Nyaya yeMurwere: Kuwana Ruregerero Rwenguva Refu neCAR-T yeMultiple Myeloma
  • Chidzidzo Chenyaya: Mhinduro Yakazara Mushure mekurapa kweCAR-T muRelapsed Multiple Myeloma
  • Kushanda kweCAR-T Therapy mukurapa Relapsed/Refractory Multiple Myeloma

  Zvidzidzo izvi zvinoratidza kuti CAR-T therapy iri kushandura sei mamiriro ekurapa kwemultiple myeloma, ichipa varwere tariro yekurarama kwenguva refu uye hupenyu huri nani.

Zviratidzo zveCD19+20CAR-T:Varwere vane B-cell non Hodgkin's lymphoma

Zviratidzo zveCD19+22CAR-T:Kurapa kwevarwere vane chirwere cheCD19 vane chirwere cheB-lymphocytic leukemia chinodzoka shure uye chisingadzoreki

Zviratidzo zveBCMACAR-T:Kurapa kwe multiple myeloma inodzokera shure uye isingadzoreki